img

Global Veterinary Active Pharmaceutical Ingredients (API) Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Active Pharmaceutical Ingredients (API) Market Research Report 2024

Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
According to Mr Accuracy reports’s new survey, global Veterinary Active Pharmaceutical Ingredients (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Active Pharmaceutical Ingredients (API) market research.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2024 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by yearpet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 146%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Active Pharmaceutical Ingredients (API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Segment by Type
Chemical Based API
Biological API
Highly Potent APl(HPAPI)

Segment by Application


CDMO
CMO

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Veterinary Active Pharmaceutical Ingredients (API) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Veterinary Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients (API)
1.2 Veterinary Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2024-2034)
1.2.2 Chemical Based API
1.2.3 Biological API
1.2.4 Highly Potent APl(HPAPI)
1.3 Veterinary Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Value by Application: (2024-2034)
1.3.2 CDMO
1.3.3 CMO
1.4 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts
1.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue 2018-2029
1.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales 2018-2029
1.4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Veterinary Active Pharmaceutical Ingredients (API) Market Competition by Manufacturers
2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2018-2024)
2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2018-2024)
2.4 Global Veterinary Active Pharmaceutical Ingredients (API) Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
2.7 Veterinary Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.7.1 Veterinary Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Active Pharmaceutical Ingredients (API) Players Market Share by Revenue
2.7.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Active Pharmaceutical Ingredients (API) Retrospective Market Scenario by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2018-2029
3.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2018-2024
3.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2024-2029
3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2018-2029
3.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2018-2024
3.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2024-2029
3.4 North America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.4.3 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.5.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.7.1 Latin America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2018-2029)
4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2018-2024)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2024-2029)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2018-2029)
4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2018-2024)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2024-2029)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2018-2029)
5.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2018-2024)
5.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2024-2029)
5.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2018-2029)
5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2018-2024)
5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2024-2029)
5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alivira Animal Health Ltd
6.1.1 Alivira Animal Health Ltd Corporation Information
6.1.2 Alivira Animal Health Ltd Description and Business Overview
6.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.1.5 Alivira Animal Health Ltd Recent Developments/Updates
6.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
6.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Corporation Information
6.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Description and Business Overview
6.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
6.3 Procyon Life Sciences
6.3.1 Procyon Life Sciences Corporation Information
6.3.2 Procyon Life Sciences Description and Business Overview
6.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.3.5 Procyon Life Sciences Recent Developments/Updates
6.4 SUANFARMAOfichem Group
6.4.1 SUANFARMAOfichem Group Corporation Information
6.4.2 SUANFARMAOfichem Group Description and Business Overview
6.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.4.5 SUANFARMAOfichem Group Recent Developments/Updates
6.5 NGL Fine-Chem Ltd
6.5.1 NGL Fine-Chem Ltd Corporation Information
6.5.2 NGL Fine-Chem Ltd Description and Business Overview
6.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
6.6 Huvepharma
6.6.1 Huvepharma Corporation Information
6.6.2 Huvepharma Description and Business Overview
6.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.6.5 Huvepharma Recent Developments/Updates
6.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
6.6.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Corporation Information
6.6.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Description and Business Overview
6.6.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
6.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
6.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Corporation Information
6.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Description and Business Overview
6.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
6.9 Menadiona
6.9.1 Menadiona Corporation Information
6.9.2 Menadiona Description and Business Overview
6.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.9.5 Menadiona Recent Developments/Updates
6.10 lndukern Group
6.10.1 lndukern Group Corporation Information
6.10.2 lndukern Group Description and Business Overview
6.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.10.5 lndukern Group Recent Developments/Updates
6.11 LasaSupergenerics Ltd.
6.11.1 LasaSupergenerics Ltd. Corporation Information
6.11.2 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Description and Business Overview
6.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2024)
6.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
6.11.5 LasaSupergenerics Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Chain Analysis
7.2 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process
7.4 Veterinary Active Pharmaceutical Ingredients (API) Sales and Marketing
7.4.1 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels
7.4.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
7.5 Veterinary Active Pharmaceutical Ingredients (API) Customers
8 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
8.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
8.2 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
8.3 Veterinary Active Pharmaceutical Ingredients (API) Market Challenges
8.4 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Veterinary Active Pharmaceutical Ingredients (API), Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients (API) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2018-2024) & (K Units)
Table 18. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2018-2024)
Table 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (K Units)
Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2018-2024)
Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2024) & (K Units)
Table 27. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (K Units)
Table 28. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2024) & (K Units)
Table 32. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Type (2018-2024)
Table 51. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Type (2024-2029)
Table 52. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2018-2024)
Table 53. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2018-2024)
Table 57. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2018-2024)
Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Application (2018-2024)
Table 61. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units) by Application (2024-2029)
Table 62. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2018-2024)
Table 63. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2018-2024)
Table 67. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2018-2024)
Table 69. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2024-2029)
Table 70. Alivira Animal Health Ltd Corporation Information
Table 71. Alivira Animal Health Ltd Description and Business Overview
Table 72. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
Table 74. Alivira Animal Health Ltd Recent Developments/Updates
Table 75. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Corporation Information
Table 76. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Description and Business Overview
Table 77. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
Table 79. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
Table 80. Procyon Life Sciences Corporation Information
Table 81. Procyon Life Sciences Description and Business Overview
Table 82. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product
Table 84. Procyon Life Sciences Recent Developments/Updates
Table 85. SUANFARMAOfichem Group Corporation Information
Table 86. SUANFARMAOfichem Group Description and Business Overview
Table 87. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product
Table 89. SUANFARMAOfichem Group Recent Developments/Updates
Table 90. NGL Fine-Chem Ltd Corporation Information
Table 91. NGL Fine-Chem Ltd Description and Business Overview
Table 92. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
Table 94. NGL Fine-Chem Ltd Recent Developments/Updates
Table 95. Huvepharma Corporation Information
Table 96. Huvepharma Description and Business Overview
Table 97. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product
Table 99. Huvepharma Recent Developments/Updates
Table 100. Jiangsu Lingyun Pharmaceutical Co. Ltd Corporation Information
Table 101. Jiangsu Lingyun Pharmaceutical Co. Ltd Description and Business Overview
Table 102. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product
Table 104. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
Table 105. Excel Veterinary HealthcareVetpharma(Insud Pharma) Corporation Information
Table 106. Excel Veterinary HealthcareVetpharma(Insud Pharma) Description and Business Overview
Table 107. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product
Table 109. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
Table 110. Menadiona Corporation Information
Table 111. Menadiona Description and Business Overview
Table 112. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product
Table 114. Menadiona Recent Developments/Updates
Table 115. lndukern Group Corporation Information
Table 116. lndukern Group Description and Business Overview
Table 117. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product
Table 119. lndukern Group Recent Developments/Updates
Table 120. LasaSupergenerics Ltd. Corporation Information
Table 121. LasaSupergenerics Ltd. Description and Business Overview
Table 122. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product
Table 124. LasaSupergenerics Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Veterinary Active Pharmaceutical Ingredients (API) Distributors List
Table 128. Veterinary Active Pharmaceutical Ingredients (API) Customers List
Table 129. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
Table 130. Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
Table 131. Veterinary Active Pharmaceutical Ingredients (API) Market Challenges
Table 132. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Active Pharmaceutical Ingredients (API)
Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Type in 2022 & 2029
Figure 4. Chemical Based API Product Picture
Figure 5. Biological API Product Picture
Figure 6. Highly Potent APl(HPAPI) Product Picture
Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Application in 2022 & 2029
Figure 9. CDMO
Figure 10. CMO
Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (2018-2029) & (US$ Million)
Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2018-2029) & (K Units)
Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/Unit) & (2018-2029)
Figure 15. Veterinary Active Pharmaceutical Ingredients (API) Report Years Considered
Figure 16. Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers in 2022
Figure 17. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Veterinary Active Pharmaceutical Ingredients (API) Players: Market Share by Revenue in 2022
Figure 19. Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2018-2029)
Figure 22. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2018-2029)
Figure 23. United States Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2018-2029)
Figure 26. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2018-2029)
Figure 27. Germany Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2018-2029)
Figure 34. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2018-2029)
Figure 42. Latin America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Type (2018-2029)
Figure 52. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Type (2018-2029)
Figure 53. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Application (2018-2029)
Figure 55. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients (API) by Application (2018-2029)
Figure 56. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/Unit) by Application (2018-2029)
Figure 57. Veterinary Active Pharmaceutical Ingredients (API) Value Chain
Figure 58. Veterinary Active Pharmaceutical Ingredients (API) Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed